Structure, expression, and regulation of the major noncollagenous matrix proteins of bone.
The noncollagenous proteins (NCPs) that predominate the bone matrix have recently been the focus of intense investigation because of their potential influence on cell attachment, Ca2+ and hydroxyapatite binding, and the mineralization of bone tissue. With the advent of molecular biology, all of the major NCPs of bone have been cloned and their amino acid sequences completely determined. While each of the proteins has distinct structural properties, some proteins appear to be part of gene families. Examples include the small proteoglycans, decorin and biglycan, as well as the gamma carboxyglutamic acid proteins, such as matrix gla protein and osteocalcin (bone gla protein). Some of the NCPs that are clearly not members of any known gene family still share several common characteristics. One such example of this "convergent evolution" is bone sialoprotein and osteopontin. Both are highly posttranslationally modified glycoproteins that share the cell attachment amino acid sequence RGD (arginine-glycine-aspartic acid), which facilitates the attachment of bone cells in vitro, yet they are clearly not related genetically. Using cDNAs and antisera as probes, the precise temporal localization of NCP expression has been determined, and it has been shown that NCPs are produced in skeletal, and in most cases, nonskeletal tissue as well. This observation implies that the functions of the NCPs are not necessarily limited to bone tissue. Many of the promoters for these genes have been isolated and functional domains determined by a combination of chloramphenicol acetyltransferase assay, gel shift, and footprint analyses. The most extensively studied promoter in the NCP category is osteocalcin, whose sensitivity to 1,25-dihydroxycholecalciferol has been delineated in detail. Future studies on the individual and cooperative activities of the NCPs in bone are likely to involve site-directed mutagenesis of cloned DNA and a combination of in vitro and in vivo functional analyses.
Young
M F
MF
Bone Research Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.
Kerr
J M
JM
Ibaraki
K
K
Heegaard
A M
AM
Robey
P G
PG
D058578:Biglycan; D001857:Bone Matrix / Q000502:physiology*; D002135:Calcium-Binding Proteins / Q000235:genetics / Q000502:physiology; D058575:Decorin; D016326:Extracellular Matrix Proteins; D015870:Gene Expression; D005821:Genetic Techniques; D006023:Glycoproteins / Q000235:genetics / Q000502:physiology; D006801:Humans; D058574:Integrin-Binding Sialoprotein; D015675:Osteocalcin / Q000235:genetics / Q000502:physiology; D015676:Osteonectin / Q000235:genetics / Q000502:physiology; D053495:Osteopontin; D010750:Phosphoproteins / Q000235:genetics / Q000502:physiology; D010980:Platelet Membrane Glycoproteins / Q000235:genetics / Q000502:physiology; D011506:Proteins / Q000737:chemistry / Q000235:genetics* / Q000502:physiology*; D011509:Proteoglycans / Q000235:genetics / Q000502:physiology; D012795:Sialoglycoproteins / Q000235:genetics / Q000502:physiology; D019699:Thrombospondins; D000097568:Matrix Gla Protein
D058578:Biglycan; D002135:Calcium-Binding Proteins; D058575:Decorin; D016326:Extracellular Matrix Proteins; D006023:Glycoproteins; D058574:Integrin-Binding Sialoprotein; D015675:Osteocalcin; D015676:Osteonectin; D053495:Osteopontin; D010750:Phosphoproteins; D010980:Platelet Membrane Glycoproteins; D011506:Proteins; D011509:Proteoglycans; D012795:Sialoglycoproteins; D019699:Thrombospondins; D000097568:Matrix Gla Protein; C546884:BGN protein, human; C546878:DCN protein, human; C546871:IBSP protein, human; C506895:SPP1 protein, human; C076105:bone acidic glycoprotein-75, human